Insulin-like growth factor receptor expression and function in human breast cancer

Kevin J. Cullen, Douglas Yee, Marc E Lippman, James Perdue, Brian Hampton, Marc E. Lippman, Neal Rosen

Research output: Contribution to journalArticle

309 Citations (Scopus)

Abstract

The insulin-like growth factors IGF-I and IGF-II are potent mitogens for several breast tumor cell lines in culture. Additionally, both IGF-I and IGF-II mRNAs are easily detected in the majority of breast tumor specimens examined, while no breast cancer epithelial cell lines we have studied express authentic IGF-I mRNA, and few lines express IGF-II mRNA. Although receptors for insulin, IGF-I, and IGF-II have been described, there is significant cross-reactivity between the various receptors and ligands in the insulin/insulin-like growth factor family, and it is not clear which receptor or receptors are responsible for the biological effects of these growth factors in this system. Using an RNase protection assay, we examined breast tumor specimens and breast cancer epithelial cell lines for expression of mRNA encoding the type I and type II IGF receptors as well as the insulin receptor. Virtually all of the specimens examined expressed mRNA for all three receptors. We then examined estrogen-dependent MCF-7 cells for the mitogenic effects of IGF-I and II in the presence of antibodies to both the type I and type II receptors. αIR-3, a monoclonal antibody which blocks the type I receptor, abolished the mitogenic effects of both IGF-I and IGF-II. It did not, however, block the mitogenic effects of insulin. We conclude that type I and type II IGF receptors are ubiquitously expressed in breast cancer, and our experiments with MCF-7 cells suggest the mitogenic effects of both IGF-I and IGF-II are mediated via the type I IGF receptor.

Original languageEnglish
Pages (from-to)48-53
Number of pages6
JournalCancer Research
Volume50
Issue number1
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Somatomedin Receptors
Insulin-Like Growth Factor II
Insulin-Like Growth Factor I
IGF Type 1 Receptor
Breast Neoplasms
Messenger RNA
IGF Type 2 Receptor
MCF-7 Cells
Insulin
Epithelial Cells
Cell Line
Insulin Receptor
Somatomedins
Ribonucleases
Tumor Cell Line
Mitogens
Intercellular Signaling Peptides and Proteins
Estrogens
Monoclonal Antibodies
Ligands

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cullen, K. J., Yee, D., Lippman, M. E., Perdue, J., Hampton, B., Lippman, M. E., & Rosen, N. (1990). Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research, 50(1), 48-53.

Insulin-like growth factor receptor expression and function in human breast cancer. / Cullen, Kevin J.; Yee, Douglas; Lippman, Marc E; Perdue, James; Hampton, Brian; Lippman, Marc E.; Rosen, Neal.

In: Cancer Research, Vol. 50, No. 1, 01.01.1990, p. 48-53.

Research output: Contribution to journalArticle

Cullen, KJ, Yee, D, Lippman, ME, Perdue, J, Hampton, B, Lippman, ME & Rosen, N 1990, 'Insulin-like growth factor receptor expression and function in human breast cancer', Cancer Research, vol. 50, no. 1, pp. 48-53.
Cullen KJ, Yee D, Lippman ME, Perdue J, Hampton B, Lippman ME et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research. 1990 Jan 1;50(1):48-53.
Cullen, Kevin J. ; Yee, Douglas ; Lippman, Marc E ; Perdue, James ; Hampton, Brian ; Lippman, Marc E. ; Rosen, Neal. / Insulin-like growth factor receptor expression and function in human breast cancer. In: Cancer Research. 1990 ; Vol. 50, No. 1. pp. 48-53.
@article{3099fbb3f7204beabbf55ab9e556eb1c,
title = "Insulin-like growth factor receptor expression and function in human breast cancer",
abstract = "The insulin-like growth factors IGF-I and IGF-II are potent mitogens for several breast tumor cell lines in culture. Additionally, both IGF-I and IGF-II mRNAs are easily detected in the majority of breast tumor specimens examined, while no breast cancer epithelial cell lines we have studied express authentic IGF-I mRNA, and few lines express IGF-II mRNA. Although receptors for insulin, IGF-I, and IGF-II have been described, there is significant cross-reactivity between the various receptors and ligands in the insulin/insulin-like growth factor family, and it is not clear which receptor or receptors are responsible for the biological effects of these growth factors in this system. Using an RNase protection assay, we examined breast tumor specimens and breast cancer epithelial cell lines for expression of mRNA encoding the type I and type II IGF receptors as well as the insulin receptor. Virtually all of the specimens examined expressed mRNA for all three receptors. We then examined estrogen-dependent MCF-7 cells for the mitogenic effects of IGF-I and II in the presence of antibodies to both the type I and type II receptors. αIR-3, a monoclonal antibody which blocks the type I receptor, abolished the mitogenic effects of both IGF-I and IGF-II. It did not, however, block the mitogenic effects of insulin. We conclude that type I and type II IGF receptors are ubiquitously expressed in breast cancer, and our experiments with MCF-7 cells suggest the mitogenic effects of both IGF-I and IGF-II are mediated via the type I IGF receptor.",
author = "Cullen, {Kevin J.} and Douglas Yee and Lippman, {Marc E} and James Perdue and Brian Hampton and Lippman, {Marc E.} and Neal Rosen",
year = "1990",
month = "1",
day = "1",
language = "English",
volume = "50",
pages = "48--53",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Insulin-like growth factor receptor expression and function in human breast cancer

AU - Cullen, Kevin J.

AU - Yee, Douglas

AU - Lippman, Marc E

AU - Perdue, James

AU - Hampton, Brian

AU - Lippman, Marc E.

AU - Rosen, Neal

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The insulin-like growth factors IGF-I and IGF-II are potent mitogens for several breast tumor cell lines in culture. Additionally, both IGF-I and IGF-II mRNAs are easily detected in the majority of breast tumor specimens examined, while no breast cancer epithelial cell lines we have studied express authentic IGF-I mRNA, and few lines express IGF-II mRNA. Although receptors for insulin, IGF-I, and IGF-II have been described, there is significant cross-reactivity between the various receptors and ligands in the insulin/insulin-like growth factor family, and it is not clear which receptor or receptors are responsible for the biological effects of these growth factors in this system. Using an RNase protection assay, we examined breast tumor specimens and breast cancer epithelial cell lines for expression of mRNA encoding the type I and type II IGF receptors as well as the insulin receptor. Virtually all of the specimens examined expressed mRNA for all three receptors. We then examined estrogen-dependent MCF-7 cells for the mitogenic effects of IGF-I and II in the presence of antibodies to both the type I and type II receptors. αIR-3, a monoclonal antibody which blocks the type I receptor, abolished the mitogenic effects of both IGF-I and IGF-II. It did not, however, block the mitogenic effects of insulin. We conclude that type I and type II IGF receptors are ubiquitously expressed in breast cancer, and our experiments with MCF-7 cells suggest the mitogenic effects of both IGF-I and IGF-II are mediated via the type I IGF receptor.

AB - The insulin-like growth factors IGF-I and IGF-II are potent mitogens for several breast tumor cell lines in culture. Additionally, both IGF-I and IGF-II mRNAs are easily detected in the majority of breast tumor specimens examined, while no breast cancer epithelial cell lines we have studied express authentic IGF-I mRNA, and few lines express IGF-II mRNA. Although receptors for insulin, IGF-I, and IGF-II have been described, there is significant cross-reactivity between the various receptors and ligands in the insulin/insulin-like growth factor family, and it is not clear which receptor or receptors are responsible for the biological effects of these growth factors in this system. Using an RNase protection assay, we examined breast tumor specimens and breast cancer epithelial cell lines for expression of mRNA encoding the type I and type II IGF receptors as well as the insulin receptor. Virtually all of the specimens examined expressed mRNA for all three receptors. We then examined estrogen-dependent MCF-7 cells for the mitogenic effects of IGF-I and II in the presence of antibodies to both the type I and type II receptors. αIR-3, a monoclonal antibody which blocks the type I receptor, abolished the mitogenic effects of both IGF-I and IGF-II. It did not, however, block the mitogenic effects of insulin. We conclude that type I and type II IGF receptors are ubiquitously expressed in breast cancer, and our experiments with MCF-7 cells suggest the mitogenic effects of both IGF-I and IGF-II are mediated via the type I IGF receptor.

UR - http://www.scopus.com/inward/record.url?scp=0025166350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025166350&partnerID=8YFLogxK

M3 - Article

C2 - 2152773

AN - SCOPUS:0025166350

VL - 50

SP - 48

EP - 53

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -